Translational Research
Accelerating the clinical application of promising research findings
Home » Translational Research » Research Faculty » Here
In this section
Topol, Eric J., M.D.
Chief Academic Officer, Scripps Health
Vice Chairman and Chief Innovation Officer, West Wireless Health Institute
The Gary & Mary West Chair of Innovative Medicine
Professor of Translational Genomics, The Scripps Research Institute
Senior Consultant, Division of Cardiovascular Diseases, Scripps Clinic
Eric J. Topol, MD, is the director of the Scripps Translational Science Institute, a National Institutes of Health funded program of the Clinical and Translational Science Award (CTSA) Consortium focused on advancing individualized medicine. He is the chief academic officer of Scripps Health, a senior consultant cardiologist practitioner at Scripps Clinic, and professor of genomics at The Scripps Research Institute.
Dr. Topol received his Bachelor of Arts with highest distinction from the University of Virginia in 1975, his doctor of medicine with honor from the University of Rochester School of Medicine in 1979, and completed internal medicine residency at University of California, San Francisco, and cardiology fellowship at Johns Hopkins University. He then was on faculty at the University of Michigan from 1985-1991, and in 2011 the University of Michigan set up the Eric J. Topol Collegiate Professorship in Cardiovascular Medicine.
In Cleveland, he chaired the Department of Cardiovascular Medicine at Cleveland Clinic for 15 years and elevated its status to rank No. 1 by U.S. News and World Report for 11 consecutive years. Dr. Topol served on the faculty of Case Western as a professor in genetics, and was founder and provost of the Cleveland Clinic Lerner College of Medicine. His work in the genomics of heart attack has led to discovery of key genes recognized by the American Heart Association twice as one of the top 10 research advances, and by TIME magazine as a “Top 10 Medical Breakthrough in 2010.”
As a leader in clinical trials of novel therapeutics, Dr. Topol administered recombinant t-PA to the first patient in 1984, pioneered the clinical development of clopidogrel (Plavix), bivalirudin (Angiomax), and abciximab (ReoPro). He was the first physician to publish safety concerns on the cardiovascular risk of Vioxx. He has more than 1,000 original peer reviewed publications and has edited more than 30 books, including the “Textbook of Interventional Cardiology” (6th ed), the “Textbook of Cardiovascular Medicine” (3rd ed), and a new book for consumers entitled “The Creative Destruction of Medicine”.
He has been a medical innovator in wireless medicine, including wireless electrocardiogram (ECG) telemetry, vital signs, and as a founder and vice chairman of the West Wireless Health Institute. Dr. Topol has been elected to the Institute of Medicine of the National Academy of Sciences, the American Association of Physicians selected as one of the founding “Rock Stars of Science” by the GEOFFREY BEENE Foundation, and recognized by the Institute of Scientific Information (ISI) to be one of the top 10 cited biomedical researchers in medicine in the past decade. In addition, Dr. Topol was recently selected as one of Modern Healthcare’s 100 Most Influential People in Healthcare.
Download a Bibliography (PDF) of Dr. Topol’s work
